Petr Jarolı́m

13.5k total citations · 3 hit papers
224 papers, 9.2k citations indexed

About

Petr Jarolı́m is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Surgery. According to data from OpenAlex, Petr Jarolı́m has authored 224 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Cardiology and Cardiovascular Medicine, 55 papers in Physiology and 50 papers in Surgery. Recurrent topics in Petr Jarolı́m's work include Acute Myocardial Infarction Research (41 papers), Erythrocyte Function and Pathophysiology (37 papers) and Heart Failure Treatment and Management (31 papers). Petr Jarolı́m is often cited by papers focused on Acute Myocardial Infarction Research (41 papers), Erythrocyte Function and Pathophysiology (37 papers) and Heart Failure Treatment and Management (31 papers). Petr Jarolı́m collaborates with scholars based in United States, Czechia and United Kingdom. Petr Jarolı́m's co-authors include David A. Morrow, Eugene Braunwald, Marc S. Sabatine, J Palek, Stacy E.F. Melanson, Vinay S. Mahajan, Sabina A. Murphy, Benjamin M. Scirica, James A. de Lemos and Christopher P. Cannon and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Petr Jarolı́m

213 papers receiving 9.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial

2014 545 citations Benjamin M. Scirica, Eugene Braunwald et al. Circulation profile →
Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy

2010 484 citations Petr Jarolı́m et al. profile →
Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial

2015 299 citations Christian T. Ruff, Robert P. Giugliano et al. profile →

Peers

Petr Jarolı́m

CCM

PHYSI

SURGE

EDM

Leong L. Ng United Kingdom

Yoshifusa Aizawa Japan

Isao Kubota Japan

Paolo Gresele Italy

H. Drexler Germany

Helmut G. Rennke United States

Christoph Bickel Germany

George F. Schreiner United States

Kari Pulkki Finland

Yasuhiko Tomino Japan

Leong L. Ng United Kingdom

Petr Jarolı́m

6.8k ×1.6

CCM

2.9k ×1.5

1.5k ×0.9

PHYSI

1.6k ×1.0

SURGE

1.3k ×0.9

EDM

Citations per year, relative to Petr Jarolı́m Petr Jarolı́m (= 1×) peers Leong L. Ng

Countries citing papers authored by Petr Jarolı́m

Since Specialization

Citations

This map shows the geographic impact of Petr Jarolı́m's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petr Jarolı́m with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petr Jarolı́m more than expected).

Fields of papers citing papers by Petr Jarolı́m

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petr Jarolı́m. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petr Jarolı́m. The network helps show where Petr Jarolı́m may publish in the future.

Co-authorship network of co-authors of Petr Jarolı́m

This figure shows the co-authorship network connecting the top 25 collaborators of Petr Jarolı́m. A scholar is included among the top collaborators of Petr Jarolı́m based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petr Jarolı́m. Petr Jarolı́m is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Monzo, Luca, Petr Jarolı́m, Barry A. Borlaug, et al.. (2025). Growth Differentiation Factor–15 Is Associated With Congestion-Related Anorexia and Weight Loss in Advanced Heart Failure. JACC Heart Failure. 13(2). 315–329. 9 indexed citations

Haller, Paul M., Petr Jarolı́m, Andrea Bellavia, et al.. (2024). Heart Failure Risk Assessment Using Biomarkers in Patients With Atrial Fibrillation. Journal of the American College of Cardiology. 84(16). 1528–1540. 7 indexed citations

Patel, Siddharth M., David A. Morrow, Andrea Bellavia, et al.. (2023). Natriuretic Peptides, Body Mass Index and Heart Failure Risk: Pooled Analyses of SAVOR-TIMI 53, DECLARE-TIMI 58 and CAMELLIA-TIMI 61. European Journal of Heart Failure. 26(2). 260–269. 4 indexed citations

Oyama, Kazuma, Robert P. Giugliano, Christian T. Ruff, et al.. (2023). Serial Assessment of Biomarkers and Heart Failure Outcomes in Patients with Atrial Fibrillation. European Journal of Heart Failure. 25(6). 832–841. 8 indexed citations

Wohlfahrt, Peter, Dominik Jenča, Vojtěch Melenovský, et al.. (2023). Attenuation of Hypocretin/Orexin Signaling Is Associated With Increased Mortality After Myocardial Infarction. Journal of the American Heart Association. 12(6). e028987–e028987. 3 indexed citations

Yeoh, Su Ern, Kieran F. Docherty, Ross T. Campbell, et al.. (2023). Endothelin-1, Outcomes in Patients With Heart Failure and Reduced Ejection Fraction, and Effects of Dapagliflozin: Findings From DAPA-HF. Circulation. 147(22). 1670–1683. 24 indexed citations

Marston, Nicholas, Amanda C. Garfinkel, Frederick Kamanu, et al.. (2022). A polygenic risk score predicts atrial fibrillation in cardiovascular disease. European Heart Journal. 44(3). 221–231. 43 indexed citations

Nilles, Eric J., Elizabeth W. Karlson, Maia Norman, et al.. (2021). Evaluation of Three Commercial and Two Non-Commercial Immunoassays for the Detection of Prior Infection to SARS-CoV-2. The Journal of Applied Laboratory Medicine. 6(6). 1561–1570. 8 indexed citations

Berg, David D., Marc P. Bonaca, Petr Jarolı́m, et al.. (2021). Cardiovascular Biomarkers and Heart Failure Risk in Stable Patients With Atherothrombotic Disease: A Nested Biomarker Study From TRA 2°P‐TIMI 50. Journal of the American Heart Association. 10(9). e018673–e018673. 8 indexed citations

10.

Oyama, Kazuma, Robert P. Giugliano, David D. Berg, et al.. (2021). Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial. European Heart Journal. 42(17). 1698–1706. 23 indexed citations

11.

Monzo, Luca, Martin Kotrč, Jan Beneš, et al.. (2019). Clinical and Humoral Determinants of Congestion in Heart Failure: Potential Role of Adiponectin. Kidney & Blood Pressure Research. 44(5). 1271–1284. 9 indexed citations

12.

Singh, Avinainder, Bradley Collins, Arman Qamar, et al.. (2017). Study of young patients with myocardial infarction: Design and rationale of the YOUNG‐MI Registry. Clinical Cardiology. 40(11). 955–961. 35 indexed citations

13.

Alberts‐Grill, Noah, Daniel Engelbertsen, De-xiu Bu, et al.. (2016). Dendritic Cell KLF2 Expression Regulates T Cell Activation and Proatherogenic Immune Responses. The Journal of Immunology. 197(12). 4651–4662. 13 indexed citations

14.

Yiadom, Maame Yaa A. B., Petr Jarolı́m, Cathy A. Jenkins, et al.. (2015). Diagnostic Implications of an Elevated Troponin in the Emergency Department. Disease Markers. 2015. 1–6. 13 indexed citations

15.

Koskinas, Konstantinos C., Yiannis S. Chatzizisis, Ahmet U. Coskun, et al.. (2013). Synergistic effect of local endothelial shear stress and systemic hypercholesterolemia on coronary atherosclerotic plaque progression and composition in pigs. DSpace@MIT (Massachusetts Institute of Technology). 10 indexed citations

16.

Melenovský, Vojtěch, Martin Kotrč, J. Polák, et al.. (2012). Availability of Energetic Substrates and Exercise Performance in Heart Failure With or Without Diabetes. European Journal of Heart Failure. 14(7). 754–763. 11 indexed citations

17.

O’Malley, Ryan B., David A. Morrow, Marc P. Bonaca, et al.. (2012). Abstract 11559: Determination of Cardiac Troponin with a Single-Molecule High-Sensitivity Assay and Outcomes in Patients with Stable Coronary Artery Disease: Analysis from PROVE IT-TIMI 22. Circulation. 126. 2 indexed citations

18.

Sabatine, Marc S., David A. Morrow, James A. de Lemos, et al.. (2011). Evaluation of Multiple Biomarkers of Cardiovascular Stress for Risk Prediction and Guiding Medical Therapy in Patients With Stable Coronary Disease. Circulation. 125(2). 233–240. 108 indexed citations

19.

Cai, Yi, Ángeles Álvarez, Pilar Alcaide, et al.. (2006). Abrogation of Functional Selectin-Ligand Expression Reduces Migration of Pathogenic CD8+ T Cells into Heart. The Journal of Immunology. 176(11). 6568–6575. 16 indexed citations

20.

Jarolı́m, Petr, Hillard Rubin, Michael Cho, et al.. (1994). Duplication of 10 nucleotides in the erythroid band 3 (AE1) gene in a kindred with hereditary spherocytosis and band 3 protein deficiency (band 3PRAGUE).. Journal of Clinical Investigation. 93(1). 121–130. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact